Browsing Tag

Mergers & Acquisitions

420 posts

Bio/Pharma M&A: Which Companies are Leading Deals in 2021?
By

By
What have been the leading mergers and acquisitions among bio/pharmaceutical companies thus far in 2021? What is the strategy behind the deals, and which companies are seeking to target the…

CDMO Trends: End-to-End Service Providers
By

By
Will the trend of combining API and drug-product development and manufacturing services into a “one-stop shop” business model for CDMOs continue? DCAT Value Chain Insights examines recent deals and investments. Tracking activity…

Pfizer To Acquire Trillium Therapeutics for $2.26 Bn
By

By
Pfizer has agreed to acquire Trillium Therapeutics, a Mississauga, Ontario, Canada-based clinical-stage immuno-oncology company, for $2.26 billion. Its two lead molecules, TTI-622 and TTI-621, block the signal-regulatory protein α (SIRPα)–CD47…

Bayer To Acquire Vividion Therapeutics in $2-Bn Deal
By

By
Bayer has agreed to acquire Vividion Therapeutics, a San Diego, California-based bio/pharmaceutical company focused on cancers and immune disorders, in a deal worth up to $2 billion ($1.5 billion upfront…

Sanofi To Acquire Translate Bio for $3.2 Bn
By

By
Sanofi has agreed to acquire Translate Bio, a clinical-stage messenger RNA (mRNA) therapeutics company, for a total equity value of approximately $3.2 billion. Translate Bio has an early-stage pipeline in…

BioNTech Acquires a Cell-Therapy Mfg Facility, R&D Platform from Gilead
By

By
BioNTech, a Mainz, Germany-based immunotherapy company, has completed its acquisition of a solid-tumor neoantigen T cell receptor (TCR) R&D platform and clinical manufacturing facility in Gaithersburg, Maryland from Kite, part…

Global Pharma Briefs: News from AstraZeneca, Merck KGaA, and Viatris
By

By
A roundup of news from Africa (BioNTech), China (Merck KGaA) and the US (AstraZeneca, Regeneron, Viatris, Takeda, BlueRock Therapeutics, and others). Africa BioNTech in Project for mRNA Malaria Vaccine; Evaluates…

GSK Appoints CEO Designate of New Consumer Healthcare Company
By

By
GlaxoSmithKline (GSK) has appointed Brian McNamara, the CEO of GSK Consumer Healthcare, a joint venture between GSK and Pfizer, as CEO Designate of a new, to-be-listed Consumer Healthcare company that…

Amgen To Acquire Teneobio in $2.5-Bn Deal
By

By
Amgen has agreed to acquire Teneobio, a Newark, California-based clinical-stage bio/pharmaceutical company developing human heavy-chain antibodies, in a deal worth up to $2.5 billion ($900 million upfront and up to…

Global Pharma Briefs: News from J&J, Merck KGaA, and MorphoSys
By

By
A roundup of news from Australia (J&J), Germany (Merck KGaA, MorphoSys), Japan (Meiji, Dong-A ST, Intas Pharmaceuticals), and the US (J&J, Kyria Therapeutics). Australia J&J Extends Innovation Partnering Office in…